Myasthenia Gravis with Anti-MuSK Antibodies: Clinical Features and Histopathological Changes

QR Code

Myasthenia Gravis with Anti-MuSK Antibodies: Clinical Features and Histopathological Changes

None

Saved in:

Bibliographic Details
Main Authors:	Angelini, Corrado, Martignago, Sara, Biscigli, Michela, Albertini, Elisa
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/26688
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Myasthenia Gravis: New Insights into the Effect of MuSK Antibodies and Acetylcholinesterase Inhibitors
by: Punga, Anna Rostedt
Published: (2011)

EPIDEMIOLOGICAL FEATURES OF MYASTHENIA GRAVIS
by: Yu. A. KHATKHE, et al.
Published: (2018-02-01)

Research of antibodies to the acetylcholine receptors in patients with myasthenia gravis
by: T. V. Romanova
Published: (2013-04-01)

Myasthenia gravis and nutrition
by: Merve Nur Uçak, et al.
Published: (2025-07-01)

Myasthenia Gravis and pregnancy
by: Georgina Burke
Published: (2024-03-01)

IMMUNOPATHOGENESIS OF MYASTHENIA GRAVIS (REVIEW)
by: E. D. Gasymly
Published: (2018-06-01)

Ocular Manifestations of Myasthenia Gravis
by: Pruitt, Joseph A., et al.
Published: (2012)

Epidemiologic studies of myasthenia gravis: literature review
by: T. M. Alekseeva, et al.
Published: (2018-10-01)

Serum cytokine profiles in patients with myasthenia gravis
by: Xuan Wu, et al.
Published: (2025-07-01)

Clinical and immunological features and treatment of myasthenia gravis in the elderly (review)
by: T. M. Alekseeva, et al.
Published: (2019-04-01)

Overlap of myasthenia gravis, myocarditis, and inflammatory myopathy secondary to immune checkpoint inhibitor (pembrolizumab) on a background of previously undiagnosed thymoma-associated acetylcholine receptor antibody-positive myasthenia gravis
by: O. V. Finleyson
Published: (2025-04-01)

Myasthenia Gravis – Current Treatment Standards and Emerging Drugs
by: Musilek, Kamil, et al.
Published: (2012)

Epidemiologic and populational aspects of myasthenia gravis in the Krasnodar Region
by: Yu. A. Khatkhe, et al.
Published: (2018-04-01)

Diagnosis of sleepiness, fatigue and depression in patients with myasthenia gravis
by: O. A. Kreis, et al.
Published: (2020-12-01)

MYASTHENIA GRAVIS AS A RISK FACTOR DURING PREGNANCY
by: A. A. Borshcheva, et al.
Published: (2018-05-01)

Treatment Approaches for Bronchopulmonary Infection in Myasthenia Gravis Patients
by: V. I. Sokolova, et al.
Published: (2020-05-01)

Results of rehabilitation of myasthenia gravis patients with subclinical respiratory disturbances
by: Yu. N. Rushkevich, et al.
Published: (2025-04-01)

Steroid myopathy in patients with myasthenia gravis: a literature review
by: S. A. Zaytsevskaya, et al.
Published: (2024-09-01)

FDA HAS APPROVED FIRST FCRN-BLOCKER FOR MYASTHENIA GRAVIS
Published: (2025-07-01)

2 cases transformation myasthenia gravis to amyotrophic lateral sclerosis
by: A. G. Sanadze, et al.
Published: (2015-02-01)

Analysis of clinical manifestations and diagnosis of late-onset myasthenia gravis
by: A. N. Khalmurzina, et al.
Published: (2020-06-01)

National guidelines for diagnosis, treatment, and management of myasthenia gravis in Israel
by: Shahar Shelly, et al.
Published: (2025-08-01)

Dyslipidemia in Myasthenia Gravis: A Systematic Review and Meta-Analysis
by: Vasileios Giannopapas, et al.
Published: (2025-06-01)

A pilot study of the immunological profile and efficacy of rituximab in muscle-specific kinase antibody-positive myasthenia gravis
by: Fengzhan Li, et al.
Published: (2025-07-01)

Positive experience of the usage of Rituximab in management of refractory myasthenia gravis in Russia
by: N. I. Shcherbakova, et al.
Published: (2015-09-01)

DIAGNOSIS AND TREATMENT OF NEW-ONSET MYASTHENIA GRAVIS IN CRITICALLY ILL PATIENTS
by: E. B. Vasilyeva, et al.
Published: (2016-03-01)

SPECIFIC MANAGEMENT OF MYASTHENIA GRAVIS IN PATIENTS UNDERGOING ABDOMINAL CANCER SURGERIES
by: V. E. GRUZDEV, et al.
Published: (2019-07-01)

The Association of Myasthenia Gravis with HLA class II Antigens in Iraqi Patients
by: Baghdad Science Journal
Published: (2013-03-01)

Pembrolizumab-induced myasthenia gravis with respiratory involvement and favorable clinical outcome
by: Cristoss Gregory, et al.
Published: (2025-07-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
by: Ivan Milanov, et al.
Published: (2025-05-01)

Immunomodulatory Treatments for Myasthenia Gravis: Plasma Exchange, Intravenous Immunoglobulins and Semiselective Immunoadsorption
by: Baggi, Fulvio, et al.
Published: (2012)

Thymoma-associated myasthenia gravis coexisting with myotonic dystrophy: a case report
by: Michiyo Miyawaki, et al.
Published: (2021-07-01)

AI-based thematic exploration to understand patients with myasthenia gravis by serological subtype
by: Louis Jackson, et al.
Published: (2025-07-01)

Case Report: Eculizumab in highly active myasthenia gravis complicated by severe infections
by: Yufei Deng, et al.
Published: (2025-07-01)

Anaesthetic Considerations in Myasthenia Gravis: Strategies to Mitigate Cholinergic Crisis during Thymectomy
by: Chhaya Mahesh Suryawanshi, et al.
Published: (2025-08-01)

Identification of potential prognostic biomarkers of thymoma with myasthenia gravis based on serum proteomics
by: Xiaoting Lin, et al.
Published: (2025-06-01)

Inflammatory imbalance and activation deficits in T cells of myasthenia gravis patients revealed by proteomic profiling
by: Amol K. Bhandage, et al.
Published: (2025-08-01)

Current understanding of the rational diagnostics and treatment of acquired myasthenia gravis. Part 2: treatment
by: S. N. Bardakov, et al.
Published: (2016-09-01)

Mycobacterium abscessus Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report
by: Daisy Lu, et al.
Published: (2025-07-01)

Autoimmune alopecia areata due to thymoma without myasthenia gravis: a case report
by: Yukino Saito, et al.
Published: (2023-05-01)